article · Annales Africaines de Medecine
Context and objectif. Hepatitis B-Delta is a serious disease due to its rapid progression to cirrhosis or liver cancer. The present study assessed the level of knowledge of physicians in Kinshasa about hepatitis B-Delta, an essential step for better patient care. Methods. An analytical cross-sectional study was conducted in 2024 among 155 physicians in Kinshasa on their knowledge of hepatitis B-Delta (screening, diagnosis, fibrosis assessment, and treatment). A logistic regression model was used to identify factors associated with knowledge. The significance level was 5%. Results. The presence of the HbS antigen for screening is recognized by 59.3% of providers. Fibrosis assessment by Fibroscan is still requested by 55.8% of providers. Viral RNA positivity and viral load reduction as an indication and therapeutic objective were recognized in 25.4% and 59.5%, respectively. Younger physicians, general practitioners, internists/infectious disease specialists, and general hospitals are less likely to be aware of hepatitis D treatment, compared to providers familiar with the diagnostic biomarker. Conclusion. Physicians in Kinshasa have insufficient knowledge of hepatitis B-Delta, hence the need to strengthen professional training to improve Hepatitis B-Delta management. Received: February 26th, 2025 Accepted: June 12th, 2025 https://dx.doi.org/10.4314/aamed.v18i4.16
This page summarises published work. The authoritative version sits with the publisher.
DOI: 10.4314/aamed.v18i4.16
Is something wrong with this record? Report it or request removal.
Discussion
Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.
No discussion yet. Open the first thread.
New to MARATTO™? Create a free account.
